USPTO serial 79331945
Serial No. 79331945
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 24, 2023
- Examiner
- SCLEIDOROVICH, JOANNA YAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79331945?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations for therapeutic purposes, namely, for the prevention and treatment of age-related macular degeneration; preparations for cell therapy, namely stem cells for medical purposes; pharmaceutical preparations for gene therapy; biologic preparations for medical purposes, namely, viral vectors for the delivery of gene therapy; biologic preparations for use in the treatment of diseases and disorders that cause blindness; gene therapy medical preparations for use in treatment of genetically based diseases and disorders; gene therapy preparations for medical purposes, namely, preparations for treating gene-linked diseases and disorders; gene therapy medical preparations for use in the treatment of ophthalmological diseases and disorders; gene therapy medical preparations for use in the treatment of diseases and disorders that cause blindness; gene therapy medical preparations for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders | ACTIVE | — |
| 010 | Medical and surgical apparatus and instruments for medical and veterinary use; medical devices, namely, devices for administering ophthalmic injections and for facilitating the administration of ophthalmic injections; ophthalmic surgery medical devices and surgical instruments; adhesive pads for medical and surgical use, namely, pads to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space; ophthalmic apparatus and instruments, namely, surgical instruments for use in the delivery and administration of fluids, biologics and pharmaceuticals during ophthalmic procedures and surgery; apparatus and instruments for dispensing or delivering preparations into the eye or structures thereof, namely, medical devices for sub-retinal delivery via suprachoroidal space of pharmaceutical and biologic, cell therapy and gene therapy products; adhesive pads for medical use, namely, to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space; magnetic pads for medical use, namely, to provide stabilization of instruments for sub-retinal delivery of pharmaceutical, biologic, cell therapy, and gene therapy products via the suprachoroidal space | ACTIVE | — |
| 041 | Education and training services in the nature of online instruction, didactic courses and workshops, hands-on workshops in the field of medical and surgical procedures and in the field of the operation and use of medical and surgical equipment; training services in the field of ophthalmic surgical procedures; training services in the field of ophthalmic surgical equipment and the use and operation thereof; educational services, namely, conducting in-person classes, seminars, conferences, exhibits, and workshops in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, conducting online classes, seminars, conferences, exhibits, and workshops in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, providing in-person instruction in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; educational services, namely, providing online instruction in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; interactive in-person training services in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment; interactive online training services in the field of ophthalmic surgery, ophthalmic surgical procedures, and the use and operation of ophthalmic surgical equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 19, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 3, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 3, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 24, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 24, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 24, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 3, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 3, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 3, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 3, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 1, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 31, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 11, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 11, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 11, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 10, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 2, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 29, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 27, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |